Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v36-FR Version v22-FR
Language French French
Date Updated 2018-06-27 2017-07-26
Drug Identification Number 02212188 02212188
Brand name IMITREX INJECTION 12MG/ML IMITREX INJECTION 12MG/ML
Common or Proper name Sumatriptan succinate injection Sumatriptan succinate injection
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients SUMATRIPTAN SUMATRIPTAN
Strength(s) 12MG 12MG
Dosage form(s) LIQUID LIQUID
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5x0.5mL 5x0.5mL
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-06-26 2017-06-26
Estimated end date 2018-06-29 Unknown
Actual end date 2018-06-26
Shortage status Resolved Actual shortage
Company comments Supply released July 2017 and August 2017 with limited quantity Supply released July 2017 with limited quantity
Health Canada comments